Comparison 4. DOPAMINERGIC DRUGS vs OTHER DRUGS.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Tardive dyskinesia: 1. No clinically important improvement ‐ medium term	1	13	Risk Ratio (IV, Fixed, 95% CI)	0.93 [0.45, 1.95]
1.1 Tetrabenazine vs Haloperidol	1	13	Risk Ratio (IV, Fixed, 95% CI)	0.93 [0.45, 1.95]
2 Tardive dyskinesia: 2. Not any improvement ‐ medium term	1	13	Risk Ratio (IV, Fixed, 95% CI)	0.39 [0.05, 2.83]
2.1 Tetrabenazine vs Haloperidol	1	13	Risk Ratio (IV, Fixed, 95% CI)	0.39 [0.05, 2.83]
3 Tardive dyskinesia: 3. Deterioration ‐ medium term	1	13	Risk Ratio (IV, Fixed, 95% CI)	1.17 [0.09, 14.92]
3.1 Tetrabenazine vs Haloperidol	1	13	Risk Ratio (IV, Fixed, 95% CI)	1.17 [0.09, 14.92]
4 Acceptability of treatment: Leaving the study early ‐ medium term	1	13	Risk Ratio (IV, Fixed, 95% CI)	0.23 [0.01, 4.00]
4.1 Tetrabenazine vs Haloperidol	1	13	Risk Ratio (IV, Fixed, 95% CI)	0.23 [0.01, 4.00]